神經調節設備市場：市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033 年）

由於影響老齡化人口的神經系統疾病的高盛行率，這個龐大的老年人口基數是神經調節劑市場的主要驅動力。此細分市場包括深部腦部刺激器（DBS）、脊髓刺激器（SCS）、迷走神經刺激器（VNS）、薦神經刺激器（SNS）、胃電刺激器（GES）和周邊神經刺激器（PNS）等。

該報告深入探討了全球神經調節劑市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。

目錄

目前市面上的神經調節劑及競爭格局

• 洞察關鍵產業趨勢
• 2015年至2033年神經調節劑各細分市場的市場總收入及市場前景
• 有關單位、平均售價和市場價值的詳細數據

全球、區域和國家見解

• 神經調節劑市場的SWOT分析
• 神經調節劑市場的競爭動態洞察與趨勢
• 按國家/地區劃分的醫療保健系統概覽
• 各國報銷政策
• 各國醫療技術法規現狀

Abstract

Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Neuromodulation Devices market for the year 2020 and beyond. Due to the large prevalence of neurological conditions impacting the aging population, this huge geriatric population base is a large driver of the neuromodulation market. Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS), Gastric Electric Stimulators (GES), Peripheral Nerve Stimulators (PNS) and Leads are tracked under this segment.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neuromodulation Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neuromodulation Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neuromodulation Devices market.
• Competitive dynamics insights and trends provided for Neuromodulation Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, LivaNova Plc, Nevro Corp, SunMed Holdings LLC, Beijing Pins Medical Co Ltd, Curonix Inc, Laborie Medical Technologies Inc, Bioness Inc, Avanos Medical Inc, IntraPace Inc, B. Braun Melsungen AG, Axonics Inc, NeuroPace Inc, Xavant Technology (Pty) Ltd, ReShape Lifesciences Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neuromodulation Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Neuromodulation Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Neuromodulation Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neuromodulation Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neuromodulation Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable